share_log

Qualigen Therapeutics Q2 EPS $(0.69) Up From $(1.10) YoY, Sales $1.63M Up From $1.43M YoY

Benzinga ·  Aug 15, 2023 08:52

Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.69) per share. This is a 37.27 percent increase over losses of $(1.10) per share from the same period last year. The company reported $1.63 million in sales this quarter. This is a 13.70 percent increase over sales of $1.43 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment